Pentara Corporation specializes in Alzheimer's disease clinical study design and efficacy analysis with at least 95% of the business devoted to the planning and implementation of efficacy analyses in said disease. This field, of which Pentara is at the forefront, is progressing rapidly in terms of measurement of disease, population selection, and efficacy analysis.
